Ipca Laboratories Ltd Financial Statement
*All values are in Rs. Cr
Particulars | Jun 2025 | Mar 2025 | Dec 2024 |
---|---|---|---|
Revenue | 1,771.92 | 1,659.93 | 1,680.09 |
Operating Expense | 1,339.98 | 1,561.39 | 1,251.59 |
Net Profit | 262.04 | -65.05 | 267.56 |
Net Profit Margin | 14.79 | -3.92 | 15.93 |
Earning Per Share | 10.33 | -2.56 | 10.55 |
EBIDTA | 429.89 | 92.24 | 430.04 |
Effective Tax Rate | 21.45 | 77.02 | 20.89 |
Particulars | Jun 2025 |
---|---|
Revenue | 1771.92 |
Operating Expense | 1339.98 |
Net Profit | 262.04 |
Net Profit Margin | 14.79 |
Earning Per Share | 10.33 |
EBIDTA | 429.89 |
Effective Tax Rate | 21.45 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Total Revenue Annual | 6,677.92 | 6,166.46 | 5,814.62 |
Operating Expenses Annual | 5,152.89 | 4,955.08 | 4,902.77 |
Operating Profit Annual | 1,314.78 | 1,189.31 | 1,023.04 |
Interest Annual | 63.04 | 120.67 | 43.92 |
Depreciation | 243.96 | 238.08 | 219.13 |
Net Profit Annual | 650.76 | 530.41 | 505.70 |
Tax Annual | 349.01 | 291.75 | 244.79 |
Particulars | Mar 2025 |
---|---|
Total Revenue Annual | 6,677.92 |
Operating Expenses Annual | 5,152.89 |
Operating Profit Annual | 1,314.78 |
Interest Annual | 63.04 |
Depreciation | 243.96 |
Net Profit Annual | 650.76 |
Tax Annual | 349.01 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Cash Flow at the Beginning | 515.28 | 1,504.83 | 945.77 |
Cash Flow from Operations | 1,374.07 | 830.51 | 762.29 |
Cash Flow from Investing | -738.81 | -1,355.18 | -709.61 |
Cash Flow from Financing | -428.44 | -464.88 | 506.38 |
Cash Flow at the End | 722.10 | 515.28 | 1,504.83 |
Particulars | Mar 2025 |
---|---|
Cash Flow at the Beginning | 515.28 |
Cash Flow from Operations | 1,374.07 |
Cash Flow from Investing | -738.81 |
Cash Flow from Financing | -428.44 |
Cash Flow at the End | 722.10 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
PBDIT Margin (%) | 23.62 | 21.08 | 17.64 |
PBIT Margin (%) | 19.85 | 17.08 | 13.70 |
PBT Margin (%) | 19.54 | 16.94 | 13.40 |
Net PROFIT Margin (%) | 9.74 | 8.60 | 8.70 |
Return On Networth / Equity (%) | 12.39 | 9.81 | 8.91 |
Return On Networth /Employed (%) | 17.21 | 14.12 | 11.67 |
Return On Assets (%) | 8.48 | 7.14 | 7.39 |
Total Debt / Equity (X) | 0.16 | 0.21 | 0.20 |
Asset Turnover Ratio (%) | 0.87 | 0.83 | 0.85 |
Particulars | Mar 2025 |
---|---|
PBDIT Margin (%) | 23.62 |
PBIT Margin (%) | 19.85 |
PBT Margin (%) | 19.54 |
Net PROFIT Margin (%) | 9.74 |
Return On Networth / Equity (%) | 12.39 |
Return On Networth /Employed (%) | 17.21 |
Return On Assets (%) | 8.48 |
Total Debt / Equity (X) | 0.16 |
Asset Turnover Ratio (%) | 0.87 |
*All values are in Rs. Cr
Standalone
Consolidated
Particulars | Mar 2025 | Mar 2024 | Mar 2023 |
---|---|---|---|
Fixed Assets Annual | 2,542.31 | 2,533.17 | 2,487.37 |
Total Current Assets Annual | 3,779.94 | 3,509.89 | 4,875.15 |
Non Current Assets Annual | 5,252.87 | 5,149.38 | 3,571.82 |
Total Shareholders Funds Annual | 6,891.62 | 6,348.71 | 5,877.30 |
Total Assets Annual | 9,070.92 | 8,659.27 | 8,446.97 |
Particulars | Mar 2025 |
---|---|
Fixed Assets Annual | 2,542.31 |
Total Current Assets Annual | 3,779.94 |
Non Current Assets Annual | 5,252.87 |
Total Shareholders Funds Annual | 6,891.62 |
Total Assets Annual | 9,070.92 |
EPS (INR)
Expected
9.19
Reported
9.19
Surprise
0.00%
Mar 2025
EPS beaten by 0.00%
Dec 2024
EPS beaten by 0.00%
Sep 2024
EPS beaten by 0.00%